Soohyung Park, Seung-Woon Rha, Byoung Geol Choi, Jae-Bin Seo, Ik Jun Choi, Sung-Il Woo, Soo-Han Kim, Tae Hoon Ahn, Jae Sang Kim, Ae-Young Her, Ji-Hun Ahn, Han Cheol Lee, Jaewoong Choi, Jin Soo Byon, Markz Rmp Sinurat, Se Yeon Choi, Jinah Cha, Su Jin Hyun, Cheol Ung Choi, Chang Gyu Park
BACKGROUND AND OBJECTIVES: Ultimaster™, a third-generation sirolimus-eluting stent using biodegradable polymer, has been introduced to overcome long term adverse vascular events, such as restenosis or stent thrombosis. In the present study, we aimed to evaluate the 12-month clinical outcomes of Ultimaster™ stents in Korean patients with coronary artery disease. METHODS: This study is a multicenter, prospective, observational registry across 12 hospitals...
April 22, 2024: Korean Circulation Journal